Shopping Cart (0)
My Account

Your Shopping Cart
Advances in Plant Genomics - Online EventTranslational Regenerative Medicine Congress 2014ISEV2014 Educational EventBiofluid Biopsies and Companion Diagnostics 2014Clinical Applications of Mass Spectrometry20% Discount OfferePoster Award PrizeBlogs

Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine

Publisher: Select Biosciences
Published: April 2010
Pages: 52

Price:



This market trends report from Select Biosciences presents the results from our latest industry tracking completed in March 2010. The data presented herein are based on primary market surveys from a worldwide respondent pool of industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as the penetrance of different research product vendors into specific segments of the stem cells marketplace.

This market report is built using data and analyses from Select Biosciences continual industry tracking of this marketplace and our analysis of this space provides up-to-date qualitative and quantitative market metrics. Primary Market Data Provide a Comprehensive and Bottom-Up Picture of the marketplace for the utilization of stem cells for drug discovery/toxicity screening efforts as well as research for regenerative medicine applications.

Specific Topics Covered in this Trends Report:

  • Primary and Up-to-Date Market Survey from a Worldwide Cross Section of the Stem Cells Industry Participants
  • Quantitative Market Penetration of Vendors Offering Products (in various segments) to the Stem Cells Research Community
  • Utilization Trends of Different Classes of Stem Cells for Drug Discovery/Toxicity Screening and Associated Trends
  • Penetrance of hESCs and iPSCs in Drug Discovery/Toxicity Screening
  • Currently Commercialized Products and Services Utilizing Stem Cells for Drug Discovery/Toxicity Screening
  • Activities Utilizing Stem Cells for Research Efforts in Regenerative Medicine
  • Cardiovascular Disease and CNS Disease Research Trends vis-a-vis Utilization of Stem Cells

This data-driven characterization of the stem cells market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development-all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations or business plans.

Report Table of Contents (TOC) [Click Here to Download PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Accreditation
“The Medical Association of Saxony certificates the two-day congress with 16 continuing education points.”


Call for papers - Advances in qPCR and dPCR 2015, Singapore
Call for papers - Advances in qPCR and dPCR 2015, Singapore
We are now accepting papers for the Advances in qPCR and dPCR meeting which will take place on the 21-22 May 2015 in Singapore.


Keynote Speaker Confirmed, Stephen Minger
We are thrilled to announce that Stephen Minger, Global Director of GE Healthcare, has confirmed he will be giving a keynote presentation at Stem Cells in Drug Discovery 2015.


Call for papers - Clinical Applications of Stem Cells 2015
Call for papers - Clinical Applications of Stem Cells 2015
We are now accepting papers for the Clinical Applications of Stem Cells meeting which will take place on the 26-27 of February 2015 in Singapore.


Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Papers Presented in the Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference can be Published in CSBJ
Computational and Structural Biotechnology Journal [CSBJ (ISSN 2001-0370)] will devote a conference special issue comprising of selected articles from the speakers/oral and poster presenters of Lab-on-a-Chip Asia- Microfluidics * Point-of-Care Diagnostics conference. Selected authors will receive an invitation to submit full length manuscripts to CSBJ. The full length manuscripts will undergo the peer-review process as per CSBJ policies. From July-2014, CSBJ will be part of ELSEVIER Open-access


Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com